David McQuarrie is a Postdoctoral Associate in Pharmacology in the Pharmacology department at Weill Cornell Medicine. He earned a Ph.D. in Bioscience from the University of Birmingham (United Kingdom) in 2025. He is Principal Investigator on a grant from The Hope Funds for Cancer Research titled "Impact of 2′-O-methylation on lung cancer growth and treatment response." Through this project, his current research examines how the chemical modification known as 2′-O-methylation influences the growth of lung cancer and how tumors respond to treatment.